Aktive Positionen von David M. Rosen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OrthoTrophix, Inc.
 OrthoTrophix, Inc. Pharmaceuticals: MajorHealth Technology OrthoTrophix, Inc. is a privately held American biopharmaceutical company founded in 2011 by Dawn McGuire, Yoshinari Kumagai, and David M. Rosen. The company is based in the area and focuses on the development and commercialization of a first-in-class disease modifying osteoarthritis drug (DMOAD). Its primary focus has been regeneration and repair of cartilage and underlying bones in the knee and other joints with its novel proprietary compounds. Yoshinari Kumagai has been the CEO since 2011. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2011 | - |
| Gründer | 01.05.2011 | - |
Karriereverlauf von David M. Rosen
Ehemalige bekannte Positionen von David M. Rosen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Nuvelo, Inc. | Geschäftsführer | 01.03.1999 | 01.07.2002 |
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Corporate Officer/Principal | - | - |
| Collagen Corp. | Corporate Officer/Principal | - | - |
Acologix, Inc.
 Acologix, Inc. Pharmaceuticals: MajorHealth Technology Acologix, Inc. develops and commercializes medicines. The company was founded by Yoshinari Kumagai in 1992 and is headquartered in Hayward, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2006 | - |
Ausbildung von David M. Rosen
| University of California, Berkeley | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Acologix, Inc.
Acologix, Inc. Pharmaceuticals: MajorHealth Technology Acologix, Inc. develops and commercializes medicines. The company was founded by Yoshinari Kumagai in 1992 and is headquartered in Hayward, CA. | Health Technology |
| Nuvelo, Inc. | Health Technology |
| Collagen Corp. | Health Technology |
Celtrix Pharmaceuticals, Inc.
Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Health Technology |
OrthoTrophix, Inc.
OrthoTrophix, Inc. Pharmaceuticals: MajorHealth Technology OrthoTrophix, Inc. is a privately held American biopharmaceutical company founded in 2011 by Dawn McGuire, Yoshinari Kumagai, and David M. Rosen. The company is based in the area and focuses on the development and commercialization of a first-in-class disease modifying osteoarthritis drug (DMOAD). Its primary focus has been regeneration and repair of cartilage and underlying bones in the knee and other joints with its novel proprietary compounds. Yoshinari Kumagai has been the CEO since 2011. | Health Technology |
- Börse
- Insiders
- David M. Rosen
- Erfahrung
